Objective: To investigate the effect of short-term intensive insulin (STII) pump therapy on serum endotrophin (ETP) levels in patients with newly diagnosed type 2 diabetes, examine the relationship ...

Que Dallara, the leader of Medtronic’s diabetes business, is keeping the focus on new products and innovation as the unit prepares to spin out into a standalone company. The diabetes unit has also ...

Multidisciplinary and specialized care before, during, and after pregnancy is crucial in improving maternal and neonatal outcomes among patients with preexisting diabetes, according to a joint ...

[Image from Medtronic] A Minnesota judge has dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE:MDT). Laura M. Provinzino, U.S. District Judge ...

Medtronic PLC investors again failed to adequately allege the device maker’s statements about its MiniMed insulin pumps constituted securities fraud, a federal court said. The latest version of the ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID ...